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 Little is understood about the complex process of synovial joint formation in early limb 
development. It has been shown that versican is highly expressed in the extracellular matrix of 
these joints (Snow et al., 2005; Shepard et al., 2007) and the knockdown of versican leads to 
malformation of the interzone, tissues that form the articular cartilage and synovial cavity 
(Nagchowdhuri et al., 2012). It is also thought that these effects impact gene expression in cells 
that are involved in the developing joint. 
Versican is chondroitin sulfate proteoglycan. It has four functional-modules: the N-
terminal domain, the C-terminal domain, and GAG-α, and GAG-β chondroitin sulfate attachment 
regions. The N-terminal domain is also known as the G1 domain and the C-terminal domain is 
also known as the G3 domain (Kimata et al., 1986 and Zimmerman et al., 1989).  
 In previous studies versican protein expression has been reduced and the G1 domain has 
been over-expressed to observe how these changes in the developing joint tissue effect gene 
expression. This study is a validation of microarray data specifically focusing on hyaluronan and 
Wnt pathway genes as they pertain to the misexpression of versican.
 RT-PCR and real-time PCR were used in this study to validate expression of the genes 
chosen. Through the use of these techniques the degree of expression has been quantified and 
compared to the fold changes observed with the microarray data. Overall, G1 versican mediated 
gene expression in the developing joint with regard to hyaluronan and Wnt pathway transcript 
regulation were in agreement with results obtained by RNA array.
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 1. Introduction 
LIMB DEVELOPMENT 
The limb develops along three axes: proximal-distal anterior-posterior and dorsal-ventral. 
Limb development begins in the limb field, the region where the limb bud forms. The limb bud 
is first represented as a bulge of cells that occurs when mesenchyme cells begin to aggregate 
underneath the ectodermal tissue. In vertebrates there are only four limb buds per embryo, with 
respect to the midline (Gilbert 2006). 
When mesenchyme cells enter the limb field they secrete Fgf10, a type of fibroblast 
growth factor, which induces the formation of the apical ectodermal ridge (AER) (Gilbert 2006, 
Ohuchi 1997). The expression of Wnt2b in the forelimb and Wnt8c in the hindlimb stabilizes the 
signaling of Fgf10, so that it remains localized in these regions of the lateral plate mesoderm. 
The AER extends along the distal margin of the developing limb and eventually becomes a 
major signaling center for the developing limb (Gilbert 2006). At the same time the AER 
secretes Fgf8 which stimulates mitosis in mesenchyme cells and causes continued expression of 
Fgf10; therefore a positive feedback system is established- in which Fgf10 induces formation of 
the AER and the AER secretes Fgf8 to continue expression of Fgf10 (Gilbert 2006). 
The anterior-posterior axis of the developing limb is established by signals from 
mesenchyme cells in the zone of polarizing activity. The major signal secreted from the zone of 
polarizing activity is transcribed from the sonic hedgehog (shh) gene. Sonic hedgehog expression 
is observed in more distal regions of the developing limbs and gives rise to the development of 
the digits.  
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The third axis of the developing limb, the dorsal-ventral axis, is organized by the non-
ridge ectoderm and the gene particularly important in this development is Wnt7a. Wnt7a 
expression is needed for dorsal patterning of the limb (Gilbert 2006) because when Wnt7a is 
knocked out in mice ventral characteristic pads develop on the dorsal and ventral side of the paw 
(Parr and McMahon 1995).  
 Wnt also signaling remains as an important regulator of subsequent stages of limb 
development through both canonical and non-canonical pathways. Non-canonical Wnt signaling 
can be divided into two sub categories: the planar cell polarity (PCP) pathway and the Wnt/Ca+2 
pathway (Komiya et al., 2008). The PCP pathway plays a role in the organization of the actin 
cytoskeleton and can impact cellular movement and structure (Komiya et al., 2008). This PCP 
mechanism may govern cellular polarity in growth plate chondrocytes, properly aligning cells for 
division and growth of the bone in length (Li and Dudley, 2009). Studies have shown that 
through loss- and gain-of-function experiments with Wnt/PCP pathway components (Fzd7 and 
Vangl2), that proliferative chondrocytes show defects in their orientation, ultimately resulting in 




Figure 1. Schematic of Wnt/PCP Pathway 
 
 Figure 1. A schematic depicting noncanonical Wnt/PCP signaling in the cell (Modified 




As the limb develops; the elbow joint forms where the prospective humerus, radius, and 
ulna intersect to form a Y-shaped cartilaginous structure. Joint formation begins with the 
formation of the interzone, an area that includes the eventual synovial cavity and articular 
cartilages of the proximal ends of the radius and ulna, and distal end of the humerus. The 
interzone is comprised of tightly-packed mesenchymal cells and in avian joints the interzone is 
usually thicker than mammalian joints (Pacifici et al., 2005). There is not much known about the 
function of the interzone, but it is believed that interzone cells are responsible for the formation 
of other joint tissues and structures (Pacifici et al., 2005).  
 It has been shown that the canonical Wnt/β-catenin signaling pathway is both sufficient 
and necessary for the induction of synovial joints in the developing chick limb. This indicates 
that Wnt/β-catenin may act at initial steps of the regulatory hierarchy in synovial joint formation 
(Guo 2004). Wnt4, Wnt9a, and Wnt16 are expressed in the forming joint in overlapping and 
complementary patterns, and may play redundant roles in activating β-catenin and joint 
formation (Guo 2004). Expression of these genes in the presumptive joint results in up-regulation 
of β-catenin and inhibition of Sox9, which leads to the induction of synovial joint formation 
(Guo 2004). Sox9 has been seen as an activator of collagen type II, which is a gene encoding a 
major structural component of cartilage (Bell 1997; Ng 1997). The first step of this induction by 
Wnt signaling is formation of interzone cells by inhibiting chondrocyte differentiation and 
inducing growth/differentiation factor 5 (Gdf5) expressions (Guo 2004, Hartmann 2000). Gdf5 
promotes the initiation of chondrogenesis, chondrocyte proliferation (Francis-West et al., 1999), 
and helps to maintain the joint in early stages of development (Storm and Kingsley, 1999).  
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Once the interzone is established cavitation and morphogenesis occur, which is the 
physical separation of the two opposing sides of the developing synovial joint and formation of 
the interlocking structures of the joint, respectively. It is believed that the glycosaminoglycan, 
hyaluronan, is involved in cavitation. Synthesis and accumulation of hyaluronan contributes to 
the breakdown of tissues in the interzone, leading to the physical separation of the opposing ends 
of the skeletal template and formation of the fluid filled cavity (Pacifici et al., 2005). Once 
cavitation occurs the morphogenetic processes begin to mold the opposing sides of the joint into 
reciprocally-shaped and interlocking structures. These morphogenetic processes occur over a 
considerable amount of developmental time and eventually lead to maturation of the joint in 
which the proximal end and the distal end are separated by a fluid filled synovial cavity (Pacifici 







 Versican, a chondroitn sulfate proteoglycan of the hyalectin family, is highly expressed in 
the extracellular matrix of developing synovial joints (Snow et al., 2005; Shepard et al., 2007).. 
A proteoglycan is a glycoprotein bearing covalently attached glycosaminoglycans (GAGs), and 
chondroitin sulfate is a long unbranched sulfated GAG consisting of repeating disaccharide units 
of glucoronate and N-acetylgalactosamine. Like other members of the hyalectin family, versican 
is a modular molecule, meaning that it is composed of different functional domains (Shinomura 
et al., 1993).  
There are three functional domains in the core protein of versican: the G1, GAGα, 
GAGβ, and G3. The G2 domain is made up of two exons that contain chondroitin sulfate 
attachment regions, GAG-α and GAG-β (Fig 7) (Wight 2002). The G1 domain is the N-terminus, 
which binds to hyaluronan, and the G3 domain is the C-terminus (Kimata et al., 1986; 
Zimmerman et al., 1989). The binding of the G1 domain and hyaluronan may be stabilized by 
linkprotein (Matsumoto et al., 2003). The G3 domain has a C-lectin like region and regulatory 
motifs crucial for cell-matrix interactions (Zhang et al., 1998). The G3 domain of versican may 
also play a role in cell proliferation due to EGF-like motifs included in the domain (Fig. 7) 
(Zhang 1998). Due to alternative splicing versican has four different isoforms: V0, V1, V2, and 
V3. The V0 isoform, has all four functional domains and V3 has only the G1 and G3 domains. 
Both the V1 and V2 isoforms contain G1 and G3 domains, but V1 has only the GAGβ domain 




Figure 2. Diagram of the 4 isoforms of Versican. 
 
 Figure 2. Diagram depicting the four isoforms of versican. The G1 functional domain is 
in red and contains the hyaluronan binding domain (HABR). The G3 domain is in purple and 
contains two epidermal growth factor repeats (EE), a lectin binding domain (L) and a 
complement regulatory region (C). The GAG-α and GAG-β domains are in blue and yellow, 




 Versican’s G1 domain is the hyaluronan binding domain for the chondroitin sulfate 
proteoglycan (Kimata et al., 1986; Zimmerman et al., 1989). Hyaluronan binds to CD44, a cell 
surface glycoprotein that is a primary receptor for hyaluronic acid (Rousche and Knudson 2002). 
It has been demonstrated that the interaction between hyaluronan and CD44 mediates cellular 
migration and adhesion (Lesley et al., 1993). At this time it is not known whether G1 versican 
modulates hyaluronan-CD44 interaction. 
 Previous studies have shown that ADAMTS family members, matrix metalloproteinases, 
have the ability to regulate versican activity through proteolytic cleavage (Capehart 2010, Sandy 
et al., 2001; Russell et al., 2003; Kern et al., 2006). DPEAAE is the terminal neoepitope 
sequence generated when the V1 isoform of versican is cleaved by ADAMTS-1, -4 or -5 (Sandy 
et al., 2001; Longpre et al., 2009).  
 The DPEAAE neoepitope is immunolocalized with full length versican, hyaluronan, link 
protein, and ADAMTS-1 in the murine joint interzone (Capehart 2010). This localization leads 
to the question as to the significance of this proteolyzed versican during joint morphogenesis. 
Because versican cleavage by ADAMTS generates a versican fragment containing the 
hyaluronan-binding G1 domain (Sandy et al., 2001), it is possible that this G1 fragment is able to 




Figure 3. DPEAAE fragment in V0 and V1 isoforms of versican. 
 
 Figure 3. Schematic showing the location of the DPEAAE neoepitope created by the 




 A previous study has shown that individual versican domains could function separately 
during establishment of cartilages in early limb skeletogenesis as seen by enlargement of skeletal 
primordia due to adenoviral-mediated over expression of G1-versican (Hudson et al., 2010). 
Moreover, versican reduction through use of adenovirally encoded shRNAs results in diminution 
of joint interzone area due to alterations in organization of interzone cells, as well as reduction of 
other ECM components including hyaluronan, collagen II, link protein 1, and tenascin 
(Nagchowdhuri et al., 2012). 
 The present study was undertaken to validate previous RNA microarray data compiled 
from four arrays that manipulated versican expression in developing joint tissues. Arrays tested 
two different groups of pooled RNA: one in which the G1 domain of versican was overexpressed 
and the other in which combinatorial versican shRNA knockdown was achieved by targeting the 
mRNA at nucleotides 320-338 and 5334-5352 (Nagchowdhuri et al., 2012). Total RNA was sent 
to the Genomics Core at University of North Carolina at Chapel Hill for performance of the 
microarray experiment. An extensive list of genes was compiled whose expression was altered 
relative to wing samples receiving control adenovirus treatment. Genes that showed potential 
relevance to joint morphogenesis were compiled into a candidate gene list to be further validated 
( Table 1). That candidate list was then consolidated to focus on transcripts involved in the 
hyaluronan and Wnt/PCP pathways in response to G1 versican over-expression. These two 
pathways are of importance to this study because of their potential involvement in joint 
development. Synthesis and accumulation of hyaluronan leads to separation of tissues in the 
interzone, which begins the cavitation process leading to synovial joint formation (Pacifici et al., 
2005). As the Wnt/PCP pathway is involved in cellular movement and orientation (Komiya et 
al., 2008, Li and Dudley, 2009), this non-canonical mechanism could affect the cavitation 
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process and joint development. The present study used RT-PCR and qRT-PCR to validate the 






Table 1. Fold change (+/-) mRNAs in response to adneo-G1 versican over-expression and 
versican knockdown in HH35 (e9) (Hamburger and Hamilton, 1951) chick elbow region. 
 
Gene Name Accession Number Fold Change 
Hyaluronan Pathway Related Genes    
Hyaluronidase 2 XM_414258 +2.5 
Hyaluronan synthase 3 XM_425137 +2.5 
UDP Glucose dehydrogenase NM_001012581 -1.9 
Link Protein 1 NM_205482 -1.7 
KIAA0527 protein XM_418822 +2.4 
Wnt Pathway Related Genes   
Wnt4 NM_204783 +2.4 
Frizzled 2 NM_204222 +2.4 
Frizzled 7 NM_204221 +2.2 
Frizzled 8 XM_426568 +2.5 
Frizzled 9 AF224319 +2.0 
Vang-like protein 2 XM_424509 +1.8 
Dachsous 1 (pcdh 16) XM_417264 +2.2 
Abl 1 tyrosine kinase  XM_422269 +2.2 
Other Genes Related to Limb/Joint Development   
Noggin BU394215 +2.8 
N-WASP TC224195 +2.2 
Sox4 TC201014 +2.9 
Gene Affected by Versican Knockdown   





SUMMARY OF CANDIDATE GENES (Table 1) 
HYAL2 – Hyaluronidase 2 (Hyal2) hydrolyzes hyaluronan of high molecular mass into 
intermediate size fragments, about 20 kDa in size (Lepperdinger 2001). It has been debated 
where these hydrolysis reactions occur because Hyal2 has a pH-optimum at approximately 4, 
which suggests that it is a lysosomal enzyme (Lepperdinger 2001). But, recently it has been 
shown that the Hyal2 protein could be a GPI-anchored cell surface protein in frog oocytes when 
the Hyal2 mRNA is injected (Lepperdinger 2001). Hyal2 has also been found as a GPI anchored 
cell-surface protein in humans (Rai SK 2001). The breakdown of hyaluronan by HYAL2 could 
lead to the disorganization of the ECM, so that cells are able to move apart during cavitation. 
Hyal2 was found to have a +2.5 fold change when the G1 domain of versican was upregulated 
(Table 1). 
 
HAS-3 – Hyaluronan synthase 3 (HAS-3) produces linear polymers of hyaluronan (HA) of 
smaller molecular sizes than those produced by HAS-1 and HAS-2 (David-Raoudi 2009). 
Despite the multifunctional role of HA in joints, little is known about the mechanisms that 
govern the activity of the HAS molecules and their relative contribution to the HA polymers 
produced by synoviocytes (David-Raoudi 2009). HAS-3 was found to have a +2.5 fold change 
when the G1 domain of versican was upregulated (Table 1), raising the possibility that shorter 
length hyaluronan chains are important during the cavitation process. 
 
UDP Glucose Dehydrogenase – The enzyme UDP-glucose dehydrogenase converts UDP-
glucose to UDP-glucuronate, a critical component of the glycosaminoglycans, hyaluronan, 
chondroitin sulfate, and heparan sulfate (Spicer 1998).. UDP-glucuronate provides the D-
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glucuronate of HA, chondroitin sulfate, and heparan sulfate and, through C5 epimerization, the 
iduronate of HS and dermatan sulfate (Kornfeld, 1980). UDP-glucose dehydrogenase had a fold 
change of -1.9 (Table 1), which suggests that production of hyaluronan may be slowed, possibly 
playing a role in destabilization of the ECM prior to cavitation. 
 
Link Protein 1 - Hyaluronan and proteoglycan link protein 1 is known to interact with the G1 
domain of versican (Matsumoto 2003). The interaction between link protein 1, hyaluronan, and 
the G1 domain of versican helps to stabilize cartilage formation in the developing joints of 
humans (Seyfried 2005). Link Protein 1 had a fold change of -1.7 (Table 1), suggesting that 
down regulation could act to de-stabilize the versican/hyaluronan interaction during joint 
development. 
 
KIAA0527 protein – Little is known regarding KIAA0527, also known as sushi domain-
containing protein (SUSD5); however, it has been shown that KIAA0527 does contain putative 
hyaluronic acid–binding domains (Vincent 2008). It is shown in Table 1 that KIAA0527 had a 
fold change of +2.4, raising the possibility that an alternative hyaluronan receptor may be 
expressed in joint-forming tissues during the cavitation event. 
 
WNT4 – Wnt signaling controls a number of processes during limb development including 
initiating outgrowth and control of patterning (Loganathan 2005). Wnt 4 expression was reported 
to be first visible at HH 27 (e5) in the developing elbow joint and from HH30 (e7) onward in the 
joint regions of the digits (Kawakami et al. 1999); however, recently Wnt 4 expression has been 
detected in the central elbow region and joint interzones of the wrist-forming region as early as 
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HH 26 (e5.5) (Loganathan 2005). It has also been shown that during later stages Wnt4 
expression localizes in joint-forming regions throughout the limb (Loganathan 2005). Expression 
of Wnt 4 suggests that it is a possible candidate involved in the joint-induction process 
(Hartmann and Tabin 2001). Wnt4 is expressed at HH28 (e6) in the interzone and mesenchyme 
surrounding joints (Church et al., 2002). Wnt4 is expressed in regions of hyaluronan synthesis 
suggesting that Wnt4 may be a regulator of hyaluronan production. High levels of hyaluronan 
prevent chondrogenesis by inhibiting the early steps of cell aggregation, and hyaluronan is also a 
key component of joint cavitation (Toole, 1981; Dowthwaite et al., 1998). It has been reported 
that Wnt4 is also involved in non-canonical Wnt signaling and that overexpression of Wnt-4 
accelerates chondrocyte differentiation, (Bergenstock 2007). Table 1 shows that Wnt4 has a fold 
change of +2.1 in tissues over-expressing the versican G1 domain. 
 
Frizzled 2,7,8,9 – The Frizzled family of genes codes for 7-transmembrane proteins that are 
receptors for the Wnt signaling proteins. It has been shown that interaction of Wnt with its 
Frizzled receptor triggers three different types of pathways: Wnt/Bcatenin pathway (canonical 
pathway), the Wnt/Ca2+ pathway and the Wnt/PCP (Davis 2008). It has been shown in Xenopus 
that overexpression of Frizzled 7 activates a non-canonical Wnt pathway leading to the 
recruitment of protein kinase C (PKC) to the membrane (Medina 1999). In Xenopus Frizzled 8 
interacts with Wnt 5a in the non-canonical pathway (Wallingford 2001) and in rat Wnt 5a and 
Frizzled 2 interact to activate non-canonical, β-catenin independent, Wnt-signaling pathway 
(Jiang 2006). It has been shown that Frizzled 9 may play a role in the canonical and non-
canonical Wnt signaling pathways in the mouse hippocampus (Zhao 2005). Little is known of 
these Frizzled genes and their interaction with their Wnt ligands in developing chick embryos. 
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Frizzled 2 had a fold change of +2.4, Frizzled 7 had a fold change of +2.2, Frizzled 8 had a fold 
change of +2.5, Frizzled 9 had a fold change of +2.0 in tissues over-expressing the versican G1 
domain (Table 1) Because Frizzleds play a role in the non-canonical/PCP pathway this 
upregulation could lead to changes in organization of the actin cytoskeleton, which could 
potentially affect cell structure and movement in the developing joint.  
 
Strabismus/Van Gogh-like protein 2 (Vangl2) – It has been shown in Drosophila, Xenopus, and 
zebrafish that Vangl2 functions in the planar cell-polarity pathway (Park 2001). Vangl2 actually 
antagonizes the canonical Wnt/β catenin pathway in zebrafish and promotes activation of c-
Jun/NH2-terminal kinase (JNK) by activating c-Jun-transcription factors, such as AP-1 (Park 
2001). Vangl2 had a +1.8 fold change in tissues over-expressing the versican G1 domain (Table 
1). Vangl2 has also been seen in gain- and lose-of-function experiments to play a role in cell 
orientation in proliferative growth plate chondrocytes (Li and Dudley, 2009). 
 
Dachsous – Dachsous is a member of the cadherin family, which encodes calcium dependent 
cell-cell adhesion molecules of the protocadherin family.  Little is known of Dachsous 
interactions in chick, but Dachsous has been seen in Drosophila to play a role in the planar cell 
polarity pathway to modulate frizzled activity (Fanto 2004). Dachsous was seen to have a fold 
change of +2.2 in tissues over-expressing the versican G1 domain (Table 1). 
 
Abl1 tyrosine kinase – The Abl1 protein is a non-receptor tyrosine kinase involved in many 
facets of mammalian development (Li, 2000). In humans ABL1 is active in processes such as 
cell differentiation, division, adhesion, and stress response (Shaul, 2005).  In mice, ABL1 is also 
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widely expressed, but most notably high levels of ABL1 are found in hyaline cartilage in the 
adult, bone tissue in newborns, and osteoblasts and associated neovasculature at sites of 
endochondral ossification in the fetus (Li, 2000). Abl1 tyrosine kinase was seen to have a fold 
change of +2.2 in tissues over-expressing the versican G1 domain (Table 1).  Abl1 tyrosine 
kinase has also been seen to play a role in actin cytoskeleton organization in the PCP/Pathway 
(Li, 2000).  
 
Noggin – Noggin is a protein that plays a crucial role in bone development, joint formation, and 
neural tube formation in mice (Guo, 2004). It has also been seen that Noggin impacts the Wnt 
pathway by interacting with Wnt9a, Wnt16, and Wnt4, all of which have been shown to be 
involved in the non-canonical Wnt pathway. Noggin is required for chondrocytes to respond to 
joint inducing signaling; a new joint only forms in a distance where active Noggin protein 
concentration recovers from inhibitory signals sent by Wnts, Gdf5, and Bmps from the 
previously formed interzone (Guo, 2004). Noggin was seen to have a fold change of +2.8 in 
tissues over-expressing the versican G1 domain (Table 2). 
 
SOX4 - SRY-related HMG box (Sox) genes encode a family of transcription factors crucial for 
embryonic development. Thirty different members of the SOX family have been found and are 
expressed in many different cell types at multiple stages of development (Wegner 1999). Sox4 
appears critical for normal development and B-cell maturation; however, its function(s) in these 
processes is not yet clear. Recent studies have demonstrated high expression of Sox4 in several 
tumors including breast cancer, colon cancer, salivary adenoid cystic carcinoma, and 
medulloblastomas, suggesting that Sox4 may play a role in tumorigenesis (Frierson 2002). Sox4 
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enhances the Wnt signaling pathway (Sinner 2007) increasing ß-catenin stability (Lee 2010). 
SOX4 was seen to have a fold change of +2.9 in tissues over-expressing the versican G1 domain 
(Table 2).  
 
Mastermind1 – Mastermind-like 1 (Maml1) is an important part of the Notch pathway whose 
function is still poorly understood. Maml1 encodes a nuclear coactivator protein that binds to the 
ankyrin repeat domain of Notch proteins; it forms a trimeric complex with the intracellular 
domain of Notch and the DNA binding protein, CSL (CBF1, Suppressor of Hairless, Lag-1) 
(Jefferies 2002). The Notch pathway could be necessary for processes involved in joint 
cavitation such as, cell proliferation and differentiation and the formation of cell boundaries 
(Williams et al., 2009).  It has also been reported that Maml1 acts as a specific coactivator of β-
catenin/TCF and plays a critical part in the Wnt pathway essential in β-catenin mediated 
tumorigenesis (Alves-Guerra 2007). Maml1 was seen to have a fold change of -1.9 in tissues 
where versican levels were reduced (Table 3).  
 
2. Methods 
 Presumptive elbow joints of the developing chick limb were microinjected at stage 25 
(HH25, e5) with 1-1.5 x 106 ifu (infectious units) of adenoviruses encoding  versican shRNAs 
(Nagchowdhuri et al., 2012) or G1-domain Hudson et al., 2010) and viral controls using 
microcapillary pipets linked to a pneumatic pump (PV820, World Precision Instruments). Once 
injected, the eggs were returned to the incubator until stage HH35 (e9). At HH35 embryos were 
removed, elbow regions dissected and RNA extracted (RiboPure Kit, Ambion). The RNA 
concentration was determined (Nano Drop Spectrophotometer ND-1000). Each extracted RNA 
yielded a 260/280 ratio of 2.11 and a concentration of 249.0 ng/µL in the G1-domain RNA and 
260/280 ratio of 2.09 and concentration of 214.1 ng/µL in the versican knockdown RNA.  
 Complementary DNA (cDNA) samples were reverse transcribed using a SuperScript III 
First Strand Synthesis Kit (Invitrogen). There were three different pools of RNA: a versican 
knockdown RNA that had two biological replicates; an overexpressed G1-domain RNA that had 
five biological replicates (two biological replicates from one set of injections and three biological 
replicates from another set of injections); and an untreated control RNA that had five biological 
replicates. All of these RNA samples were reverse transcribed with equal amounts of RNA (750 
ng/reaction) using oligodT priming. Once RNA was reverse transcribed into cDNA, samples 
were diluted 5 fold for reverse transcription PCR (RT-PCR). 
 Primers for candidate genes were designed using the BLAST function on the NCBI 
website (http://blast.ncbi.nlm.nih.gov/). Forward and reverse primers were designed and the 
predicted amplicon sequence was searched against the chick genome to ensure that the amplicon 
was sequence specific. Once primers were designed they were tested using PCR to ensure that 
the expected amplicon could be amplified in each cDNA pool.   
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 RT-PCR reactions were carried out in 25 µL volumes with 2.5 µL Buffer, 0.75 µL 
MgCl2, 0.5 dNTPs, 0.125µL Taq Polymerase, 1.0 µL template cDNA, and 2.5 µL of forward and 
reverse primer (0.3 mM). RT-PCR was carried out in a thermocycler (Eppendorf Mastercycler 
Gradient) for 35 cycles with an initial denaturation step at 94°C for 2:00 min, a second 
denaturation at 94°C for 0:30 sec, an annealing step at the optimal annealing temperature for the 
specific primer pairs for 0:30 sec, an elongation step at 72°C for 0:30 sec. Once all the cycles 
were complete there was a final elongation step at 72°C for 10:00 min and then the machine 
would hold the finished PCR product at 15°C until removal for analysis.  
 Products were analyzed by agarose gel electrophoresis on 1.5% gels. Gels were made 
with 50mL of 1X TAE Buffer and 0.75g of agarose. Once completed dissolved and cooled 5µL 
of ethidium bromide was added and poured into the electrophoresis tray. Gels polymerized for a 
minimum of 45 minutes before diluted PCR products were loaded into the wells. PCR products 
were diluted 1:4 with loading dye (Blue Juice, Invitrogen). Gels were run using approximately 
85V over one hour, and then viewed under ultraviolent light to observe PCR products. The 
primer pairs that were successful in this procedure are listed in Table 2. Some gene candidates 
were removed from further investigation after this point because successful primers were unable 
to be made, following multiple attempts.  
 Primer pairs successful for RT-PCR were then used in real-time PCR experiments to 
determine levels of candidate gene expression in the RNA populations extracted from versican 
adeno-shRNA and -G1 infected limbs relative to viral control injections. RT2 SYBR Green/ROX 
qPCR Master Mix (SA Biosciences) was used for real-time PCR, this mixture is specifically 
used for the qPCR machine (ABI 7300). The real-time reactions were carried out in 25µL 
volumes containing 1.0µL of cDNA, 12.5µL of RT2 SYBR Green/ROX qPCR Master Mix (SA 
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Biosciences), 0.5µL of both the forward and reverse primer. The recommended real-time thermal 
cycler program provided by SA Biosciences was followed, which consisted of a 10 minute initial 
denaturation at 95°C, then 45 cycles of 95°C for 15 seconds, 60°C for 60 seconds. β-actin 
primers (F: CACAGATCATGTTTGAGACCTT, R: CATCACAATACCAGTGGTACG; 
Accession # L08165; DeBoever et al., 2008) and GAPDH (F: GGCACGCCATCACTATC, R: 
CCTGCATCTGCCCATTT; Accession # K01458.1; DeBoever et al., 2008) were used as 
housekeeping genes.  
 Fold change was calculated using the Pfaffl method (2001) for relative quantification 
calculations by normalizing the CT values with the house keeping genes to obtain a ∆CT. ∆CT 
was then analyzed relative to untreated control ∆CT to obtain ∆∆CT. The equation 2-∆∆CT was 
used to calculate fold change (Pfaffl, 2001). Efficiency was also calculated using the formula E = 
(10−1/slope) – 1 (Higuchi et al., 1993). The slope was calculated from standard curves generated by 
plotting the CT vs. the log of the dilution of template. Statistical significance was also calculated 
using the Student t-test.
3. Results 
 To validate the previously obtained microarray data another form of quantifiable 
expression needed to be shown. Real-time PCR is becoming a more widely used technique to 
quantify expression (Nolan et al., 2006). Other steps had to take place before the real-time PCR 
could be undertaken, including primer design and RT-PCR. Primer design was of the utmost 
importance because amplicons needed to be sequence specific to that particular gene. RT-PCR 
verified that products of the predicted size could be amplified from the template cDNA. RT-PCR 
demonstrating presence of transcripts, but could not quantify the level of expression. Through a 
series of calculations real-time PCR could yield quantifiable fold change expressions levels that 
could validate the microarray data.  
 
RT-PCR 
 Primers were designed for all genes in the candidate list (Table 1) and tested using RT-
PCR. Primer pairs shown in Table 2 were working primer pairs used for further analysis. Genes 
for which successful primer pairs could not be obtained were Frizzled 8, Sox4, and N-WASP. 
Multiple primer pairs were designed and tested before it was decided to omit further analysis of 
those genes. When a band was visible at the predicted length, then the PCR product was accepted 
as successful. Figure 4 shows bands of these PCR products; once accepted, primer pairs were 
used for real-time PCR. 





Table 2. Genes, Accession numbers, primer pairs, and expected sequence length for candidate 
genes tested in RT-PCR and Real Time-PCR. 
 
 
Gene Name Accession # F. Primer: 5’-3’ R. Primer: 5’-3’ Sequence  Length 
Mastermind XM_414606 GCAGTCCAGCTCCAGCCAGC 
GAACAGCAGCACCCT
GGCCC 179 
CABL XM_422269 ATTGTGGGCACGGTCCTGTTCC 
TGCCTGGGGTTCGACA
TCGC 150 
Dachsous XM_417264 GCGAGGACCCAATGGGGTGC 
GGCGGGAGCGTTGTCG
TTGA 175 
Frizzled 2 NM_204222 TTCCGCCAGCACTGGGAGCG 
CGCTCACACCGTGGTC
GCGCC 245 
Frizzled 7 NM_204221 CTGCTGTCAAAACCATCACC 
GCACCATCAGCTTCTC
CAGC 243 
Frizzled 9 AF224319 CTCACCTTCCTGCTCGACCCGC 
CAGAGCGAGCTGGCC
ATGCC 239 
HYAL 2 XM_414258 GGCTGCAGGAGAACATCGG 
GCGTAGCGCAGCGTTG
TCAC 247 
HAS3 XM_425137 GTGGACTACATCCAGGTGTG 
GAAGGCCATCCAGTAC
CGCA 180 
KIAA0527 XM_418822.2 ACCACGGGATGGCTGGCTGA 
TCTCCGCACGGCTTGT
CTTC 167 
Link Protein NM_205482 GACACCACAGAAAGAGCTAC 
GCTGTGTCGTCCTCTA
ATCC 154 
Noggin NM_204123.1 CGCTTTTGGCCCCGGTACGT 
GATGGGGTACTGGATG
GGGA 174 
Vangl2 XM_424509 GAGGACAGCGCGCACCTGGAC 
CGCGCGGAAGACGAA
GACGC 264 
UDPGDH NM_001012581 GACAGGGTGCTCATTGGTGG 
GCTGCCTCCAAACCCA
ACAC 310 









Figure 4. PCR products for genes listed in Table 2. All gels were 1.5 % agarose. A. Bands for 
HYAL2, UDPG, LINK, KIAA, MASMD, WNT4, FZD2, FZD7, FZD9, and VANGL with 
corresponding sequence sizes were compared to a 1KB standard ladder. B. Bands from for 
HAS3, NOG, CABL, and DACH with corresponding sequence sizes were compared to a 100 
base pair ladder. 
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Real Time PCR 
β-Actin reference gene 
Real-time PCR experiments were performed to quantify levels of expression in the 
template cDNA. Initially, two biological replicates of both G1-domain overexpression and knock 
down template cDNA were used, but due to the number of genes affected by G1 versican over-
expression and potential relevance to ongoing research regarding potential role of a G1 
proteolytic fragment in joint development, subsequent experiments involved only samples in 
which the G1 domain was over expressed. These latter injections yielded three additional pooled 
biological replicates of G1 and control RNA that was reverse transcribed into cDNA and used 
for additional real-time PCR testing.  
 A total of five biological replicates of G1 overexpressed template cDNA were used to 
quantify expression levels (Fig. 5). These fold changes were tabulated over a range of 3-10 
experiments and each gene of interest had at least ten technical replicates (Fig. 5). With the 
exception of FZD2, which was down regulated, fold changes were noted in the direction 
expected from earlier microarray data.  
The average fold changes were calculated with primer efficiency calculated in using the 
formula: E = (10−1/slope) – 1 (Higuchi et al., 1993) (Fig 6). Some genes from Figure 5 do not 
appear in Fig 6 due to their primer efficiency being outside the acceptable range of ~80-120% 
(Table 3) (HAS3, WNT4, VANGL, and CABL). Dissociation curves were analyzed to verify 
these primer deficiencies (Fig. 7). The dissociation curves for HAS3, WNT4, VANGL, and 
CABL were unacceptable because of the multiple peaks that formed during dissociation. The 
dissociation curve for GAPDH is shown as a reference of what an acceptable dissociation curve, 
uniform peaks at one temperature.  
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Appendix B shows averaged fold changes of the genes of interest when versican level 
was knocked down. These fold changes were also tabulated over five experiments and each gene 
of interest had at least ten technical replicates. These experiments were conducted using the 
initial two biological replicate pools. MASMD which had been noticeably affected by versican 
being knocked down showed a similar trend of down-regulation.  
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Figure 5. Average fold change from real time PCR data using template cDNA samples in which 
versican G1 domain was overexpressed. Panels A and B are the same treatments separated such 
that differences infold change can be better appreciated. Bars denote standard error of the mean 








Figure 6. Average fold change from all real time PCR data using template cDNA in which 
versican G1 domain was overexpressed. Panels A and B are the same treatments separated such 
that differences infold change can be better appreciated. Bars denote standard error of the mean 
and asterisks denote significance  at p<  0.05. Efficicencies (Table 3) have been calculated into 
these fold changes.  
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Table 3 shows the efficiencies that were calculated using the formula: E = (10−1/slope) – 1 
(Higuchi et al., 1993). The slope was generated from the standard curve graph. 
  



















Figure 7. Melting curves for CABL, HAS3, VANGL, WNT4, and GAPDH. 
 
 
Figure 7 shows the melting curve at which the PCR products created by real-time PCR begin to 
denature. A. Melting curve for CABL. B. Melting curve for HAS3. C. Melting curve for 
VANGL. D. Melting curve for WNT4. E. Melting curve for GAPDH. Temperature is on the x-





GAPDH reference gene  
 To ensure that the housekeeping gene, β-actin, was reliable a second housekeeping gene 
was used in real-time PCR experiments. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
was used as the second reference gene to strengthen the results found from experiments utilizing 
β-actin. Real-time PCR experiments normalized using GAPDH were performed with newly 
extracted RNA, so that three biological replicates could be represented in the experiments. 
 Versican G1-domain template cDNA was used to perform real-time PCR. CT values from 
a subset of genes were normalized using GAPDH and β-Actin simultaneously and average fold 
changes calculated (Fig. 8). The genes included in the subset were those that had acceptable 
primer efficiencies (~80-120%) in Table 3. Figure 9 is a comparison between the two 
housekeeping genes. There were slight differences in the average fold changes when the CT 
values were normalized with GAPDH, but up-regulation or down-regulation trends were similar 
for each candidate gene being tested.   
  
Combined Reference Genes 
 Since the two reference genes were relatively similar in their respective fold change 
averages, the two were averaged together to achieve a more robust normalization of the data 
(Fig. 10). The efficiencies from Table 3 have been factored into the combined normalized fold 
change averages using the equation: E = (10−1/slope) – 1 (Higuchi et al., 1993).  
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 Figure 8. Calculated fold changes of real-time PCR experiments using template cDNA in 
which versican G1 domain was over expressed. Panels A and B are the same treatments 
separated such that differences infold change can be better appreciated. Bars denote standard 
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error of the mean and the astericks denote signifcance at p < 0.05. Efficiencies (Table 3) are 
calculated into these average fold changes.  
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 Figure 9. A subset of average fold changes to compare the two reference genes, β-Actin 
and GAPDH. Panels A and B are the same treatments separated such that differences infold 
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change can be better appreciated. Bars denote standard error of the mean and the astericks denote 








Figure 10. Calculated fold changes of real-time PCR experiments in which versican G1 domain 
was over expressed and normalized with a combined average of both, β-actin and GAPDH, 
reference genes. Panels A and B are the same treatments separated such that differences infold 
change can be better appreciated. Bars denote standard error of the mean and the astericks denote 
signifcance at p < 0.05. Efficiencies (Table 3) are calculated into these average fold changes
4. Discussion 
 Versican is a proteoglycan expressed in the interzone of the developing synovial joint in 
the chick limb (Shepard 2007). Versican has three modular domains: G1, G2, and G3 (Kimata et 
al., 1986; Zimmerman et al., 1989) and due to alternative splicing yields four different isoforms 
(Shinomura et al., 1993). Moreover, ADAMTS-1 cleaves V0 and V1 isoforms of versican to 
leave a terminal neoepitope, DPEAAE, at the carboxy end of a proteolytic fragment containg the 
G1 domain (Capehart 2010). This neoepitope co-localized with hyaluronan, full length versican, 
and link protein in the murine joint interzone (Capehart 2010). This led us to hypothesize that the 
G1-domain of versican may have a role in joint development and may be able to function 
separately from the rest of the proteoglycan.  
 To investigate the possibility of an independent action for G1-domain, an adenoviral 
construct that overexpressed the G1 domain of versican was injected into the presumptive elbow 
joints of chick embryos at HH25 (e5) (Hamburger and Hamilton, 1951) and used for analysis at 
HH35 (e9) (Hamburger and Hamilton, 1951), the stage when early joint cavitation is under way. 
In a separate experiment adenoviral constructs used a combination of knockdown shRNA 
constructs that targeted the versican mRNA at nucleotides 320-338 and 5334-5352 
(Nagchowdhuri et al., 2012). The RNA from the two of injections were isolated and sent to the 
Genomics Core at University of North Carolina at Chapel Hill for microarray analysis. From 
microarray results a candidate list was formulated to investigate genes that showed potential 
relevance to joint morphogenesis. Genes chosen were involved in hyaluronan and Wnt pathways.  
 The aim of this investigation was to validate the earlier microarray data through use of 
RT-PCR and real-time PCR. RT-PCR was used to ensure that the primers designed for each gene 
were successful at amplifying the desired sequence (Fig. 4). Some gene primers were unable to 
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be generated: FZD8, SOX4, and N-WASP. Multiple attempts were made to design these primers 
before excluding them from further analysis. Primers that yielded amplicons of the predicted size 
from pooled samples utilized for the microarray analysis were used for real-time PCR.  
 Real-time PCR is a technique that amplifies a targeted DNA sequence while 
simultaneously quantifying the expression. The method of detection used in this study was RT2 
SYBR Green/ROX qPCR Master Mix (SA Biosciences) that binds to double stranded DNA. 
When the SYBR green anneals to the double stranded DNA it fluoresces and this fluorescence is 
detected by the PCR instrument and graphed as cycle number vs. fluorescence intensity. The CT 
value is where the fluorescence crosses the threshold, which was chosen by the experimenter (1.0 
was the threshold for all experiments). Once the CT is obtained from the real-time PCR run fold 
change can be calculated. Fold change is calculated using the Pfaffl method (2001) for relative 
quantification calculations by normalizing the CT values with housekeeping genes to obtain a 
∆CT. ∆CT is then analyzed relative to untreated control ∆CT to obtain ∆∆CT. The equation 2-∆∆CT 
is then used to calculate fold change.  
 Efficiency was also calculated using the formula E = (10−1/slope) – 1 (Higuchi et al., 1993). 
The slope was calculated from standard curves generated by plotting the CT vs. the log of the 
dilution of template. Efficiency is then used to modify the fold change calculation to obtain a 
more accurate fold change using the formula: 2-∆∆CT*E.  
 Real-time PCR experiments were initially run with genes that had successful primer pairs 
from RT-PCR (Table 2). The CT values returned from the real-time PCR experiments were 
normalized with the housekeeping gene, β-Actin. Using these CT values, fold changes could be 
calculated (Fig 5 and 6). These experiments used five biological replicates over multiple 
experiments (3-10) and each experiment had three technical replicates for each biological 
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replicate. With the exception of a few genes, the real-time PCR data tended to agree with the 
microarray data. The fold changes from the two different methods of analysis were not expected 
to be exactly the same, but expectations were to see fold changes in the same direction. 
 A second housekeeping gene, GAPDH, was added to experiments to strengthen results of 
the study. Real-time PCR was performed with a selected subset of genes to yield CT values and 
normalized with both β-Actin and GAPDH. The respective fold changes were calculated and 
compared (Fig 8 and 9). There were slight differences in average fold changes, but the fold 
changes were so similar that CT values for the two housekeeping genes were averaged together 
for each cDNA pool to achieve one combined fold change for gene expression (Fig 10).  
 Mastermind1 was the only gene chosen for use in the present study when versican 
expression was reduced (App. B). As seen in Appendix B MASMD fold change was 
significantly reduced relative to the control. But, moving forward with experimentation this RNA 
was no longer used because of growing interest in the potential role of the versican G1-domain in 
the developing joint. 
 Genes with reasonable efficiency (~80-120%) were used for continued experimentation: 
HYAL2, KIAA, LINK, FZD9, DACH, and FZD7. Other genes were omitted either because of 
poor primer efficiency (CABL, VANGL2, HAS3, and WNT4) or they were less relevant to 
ongoing studies by this laboratory (UDPG, NOGG, and FZD2). The poor efficiencies were made 
clearer upon looking at the dissociation curves for CABL, VANGL2, HAS3, and WNT4 (Fig. 7). 
In each case there were multiple peaks denoting that multiple products were being made, either 
from primers not being sequence specific or the primers were self-annealing. All expected 
amplicon sequences were checked in the NCBI database against the Gallus gallus genome to 
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ensure sequence specificity, so unless is the primers were binding sequences not present in the 
database, then the likelihood is that primers were self annealing. 
 HYAL2 is an enzyme that hydrolyzes long, high molecular mass hyaluronan strands 
(Lepperdinger 2001). If HYAL2 was upregulated and expressed at the cell surface, when the G1 
domain is expressed, then the joint interzone may become saturated with small molecular weight 
hyaluronan fragments. This could possibly be a mechanism to destabilize rigidity of the 
extracellular matrix. 
 From real-time PCR data the KIAA0527 protein was upregulated, relative to the control, 
by the G1-domain of versican being overexpressed. Little is known regarding this KIAA protein, 
its sequence suggests that is a putative hyaluronan binding protein, much like CD44 (Vincent 
2008). If it is a hyaluronan binding protein it could be involved in G1-hyaluronan dynamics in 
this interzone pathway and act as an alternative CD44 receptor. However, the mechanisms that 
control KIAA0527’s intracellular activities are still unknown. It would definitely be beneficial to 
perform in situ hybridization with KIAA to see where it is being expressed in the joint interzone, 
because this has not been done before.  
  Frizzled-9 and frizzled-7 are both involved in the non-canonical Wnt-pathway as 
transmembrane Wnt receptors (Zhao 2005; Medina 1999, respectively). FZD9 had fold changes 
that were increased compared to the control, which agrees with the microarray data. FZD7 had 
robust upregulation according to real-time data, which trended in the same way as the microarray 
result. These upregulation of FZD7 and FZD9 occur when the G1 domain of versican was 
overexpressed. As FZD7 works within the PCP Pathway, this pathway could be working to 
maintain a well ordered laminar structure among interzone mesenchyme so that when cavitation 
begins, cells are able to move apart in an organized fashion.   
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 Dachsous is also upregulated in the real-time PCR data, as well (Fig. 10). This 
upregulation trend agrees with the microarray data from Table 1. Dachsous activity is still 
unknown in chick, although it has been seen to play a role in the PCP-pathway to modulate 
frizzled receptors in Drosophila (Fanto 2004). DACH has also been implicated in controlling the 
orientation of microtubules to establish planar cell polarity in the wing of Drosophila (Harumoto 
et al., 2010).    
 HAS3 transcript was both upregulated when the G1 domain was overexpressed before 
efficiency was calculated into the fold change. The large primer efficiency could be due to poor 
primer design or primer dimer formation during the PCR reaction. It could be due to HAS3 being 
a low-copy transcript (Tien and Spicer 2005), so when the cDNA becomes increasingly diluted 
for efficiency calculation there are only very few transcripts for the primers to bind to. As a note, 
it was particularly hard to design primers for HAS3. Bovine RNA was kindly provided by the 
Warren Knudson Lab, Brody School of Medicine, and a DNA sequence that overlapped in 
bovine and chick was found and tested to produce the primer pair utilized for amplification of 
HAS3.  
 The G1-domain of versican interacts with hyaluronan, which in turn may be bound to the 
cell surface receptor, CD44. At this time mechanisms involved in G1-domain over-expression 
effects on hyaluronan-CD44 interaction are unknown, but the microarray data and the real-time 
PCR data suggest that the G1-domain may play some role in this interaction. The G3-domain of 
versican binds to cell surface receptors, such as, fibronectin, fibrillin, fibulin, and collagen type I 
and could possibly interact with other EGF receptors (Zhang et al., 1998). The binding of the 
different domains of versican help to create a rigid extracellular matrix prior to cavitation. 
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 When ADAMTS-1 cleaves the G1-domain away from the rest of the proteoglycan cell-
cell interactions are disrupted and cells begin to push apart. And because of the upregulation of 
HYAL2 there is an abundant of small hyaluronan fragments possibly saturating the CD44 cell 
surface receptors. The upregulation of KIAA0527 is particularly interesting because it could be 
playing a role as a putative cell surface, hyaluronan binding protein, further experimentation 
would be needed to confirm this.  
 When versican is completely removed from mice limbs are noticeably shorter in length 
and the joints are tilted (Choocheep et al., 2010). Versican knockdown experiments show that the 
cells in the interzone become disorganized in the absence of versican, possibly due to effects in 
the PCP pathway (Nagchowhurdi 2012). The microarray data and the real-time PCR data, 
through upregulation of known PCP pathway components, suggest that the interaction between 
the G1-domain and hyaluronan could be controlling downstream events in the cell to modulate 
the cytoskeleton through the PCP-pathway. If the PCP pathway is regulated by G1, this could 
help regulate joint orientation by helping cells to align properly in the interzone prior to and 
during cavitation. 
 There is an increasing appreciation for extra cellular matrix impacts on gene expression. 
We have shown that when the G1 domain of version is overexpressed there are changes in gene 
expression, such as the upregulation of PCP pathway genes. Though the mechanisms are still 
unclear, the data suggests that through hyaluronan-CD44 interaction the G1 domain of versican 
is playing a role in intracellular gene expression. Peterson et al. (2004) showed evidence of the 
hyaluronan-CD44 interaction playing a role in intracellular gene expression by affecting the 
BMP pathway through Smad1 binding to the CD44 cytoplasmic tail. It is possible that the G1 
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domain could be affecting the PCP pathway genes through a similar hyaluronan-CD44 
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Appendix B. Average fold changes from real-time PCR using template cDNA samples in which 
versican has been knockdown. Bars denote standard error of the mean and asterisks denote 




Appendix C. In Situ Hybridization Primer Pairs. 
Gene 
Name 
Accession # F. Primer: 5’-3’ R. Primer: 5’-3’ 
Sequence   
Length 
CABL XM_422269 ATTGTGGGCACGGTCCTTTCC GCTGCTCTCACTCTCACGAACC 495 
Dachsous XM_417264 CACTGGTGCTCTCTCTGTTG CAGGGTCAGTGGCACGCAGG 542 
Frizzled 2 NM_204222 CGGCCACATGTTCTTCAACGAGG TGAGCCCCACGAAGCAGACG 527 
Frizzled 8 XM_426568 GCATCCGCAGCGTGATCAAG TCACACATGGGACAGCGGGAC 443 
Frizzled 9 AF224319 TGCTCACCTTCCTGCTCGACCC AAAGACAGCCACGGTGGGCAC 776 






UDPGDH NM_001012581 CTGTATCGGTGCTGGCTATG GCTGCCTCCAAACCCAACAC 802 
Wnt4 NM_204783 CTCACAGTCCTTTGTCGACG CCCGATGGCAGGGTTTGCAC 536 
 
Appendix C. Successful primer pairs originally designed for probe designed for in situ 
hybridization. 
 
 
  
